Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZN | AMGN | VRTX | REGN | GSK |
| Company | Enzon Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.1450 | 306.42 | 451.90 | 984.04 | 45.42 |
| High | 0.1450 | 307.39 | 456.17 | 988.77 | 45.45 |
| Low | 0.1450 | 304.00 | 449.42 | 983.16 | 45.20 |
| Last | 0.1450 | 304.81 | 455.14 | 986.11 | 45.16 |
| Change | +0.0150 | -1.69 | +4.34 | +5.54 | +0.01 |
| % Change | +11.54% | -0.55% | +0.96% | +0.56% | +0.02% |
| Volume | 3,400 | 230,081 | 204,819 | 44,185 | 514,473 |
| 20-Day Average Volume | 40,275 | 2,756,221 | 1,118,299 | 413,856 | 3,842,822 |
| Previous Close | 0.1300 | 306.50 | 450.80 | 980.57 | 45.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0929 | 303.22 | 424.44 | 961.40 | 44.28 |
| 20-Day Raw Stochastic | 97.46% | 68.27% | 98.14% | 88.66% | 85.13% |
| 20-Day Relative Strength | 69.54% | 57.55% | 73.69% | 59.88% | 62.96% |
| Weighted Alpha | -38.40 | +36.80 | +39.97 | +35.02 | +35.78 |
| Today's Opinion | 24% Buy | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 24% Buy | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 72% Sell | 8% Buy | 8% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +52.79% since 05/17/24 | -2.20% since 05/17/24 | +2.19% since 05/17/24 | +0.26% since 05/17/24 | +0.61% since 05/17/24 |
| Low | 0.0823 on 05/20/24 | 304.38 on 05/23/24 | 437.46 on 05/21/24 | 975.73 on 05/23/24 | 44.40 on 05/20/24 |
| High | 0.1469 on 05/23/24 | 316.67 on 05/21/24 | 456.17 on 05/24/24 | 997.87 on 05/22/24 | 45.79 on 05/22/24 |
| 1-Month | |||||
| %Chg | +85.90% since 04/23/24 | +11.93% since 04/24/24 | +13.53% since 04/24/24 | +8.64% since 04/24/24 | +10.76% since 04/24/24 |
| Low | 0.0720 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 40.81 on 04/25/24 |
| High | 0.1469 on 05/23/24 | 322.60 on 05/03/24 | 456.17 on 05/24/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +70.59% since 02/23/24 | +5.67% since 02/23/24 | +5.78% since 02/23/24 | +0.37% since 02/23/24 | +7.19% since 02/23/24 |
| Low | 0.0600 on 04/01/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 0.1469 on 05/23/24 | 322.60 on 05/03/24 | 456.17 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +20.93% since 11/24/23 | +15.12% since 11/24/23 | +28.87% since 11/24/23 | +23.37% since 11/24/23 | +26.38% since 11/24/23 |
| Low | 0.0600 on 04/01/24 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.35 on 11/29/23 |
| High | 0.1469 on 05/23/24 | 329.72 on 02/05/24 | 456.17 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,649 | 164,417,328 | 116,330,288 | 108,045,080 | 93,570,672 |
| Shares Outstanding, K | 74,220 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | 1,370,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | 320,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.39 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 05/10/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | 0.240 on 09/30/19 | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | 09/30/19 | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 12.99 | 16.61 | 29.72 | 26.51 | 11.33 |